| Market Cap | ₹31,345Cr |
| ROE | 7.63% |
| P/E Ratio(TTM) | 40.70 |
| EPS(TTM) | 46.75 |
| P/B Ratio | 3.43 |
| Dividend Yield | 0.95% |
| Industry P/E | 34.86 |
| Book Value | 555.41 |
| Debt to Equity | 0.03 |
| Face Value | 1 |
| Parent Organisation | Gland Pharma Limited |
| Managing Director | Mr. Srinivasa Sadu |
| NSE Symbol | GLAND |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.48 | ||
| Ajanta Pharma | NA (0.00%) | 32.05 | ||
| Eris Lifesciences | NA (0.00%) | 53.90 | ||
| Sai Life Sciences | NA (0.00%) | 77.33 |